Cargando…

Increased expression of ECT2 predicts the poor prognosis of breast cancer patients

Breast cancer is the most common malignancy and the second leading cause of cancer-related death in women. Recent studies have indicated that aberrant activation of Rho GTPases relates to the malignant properties of breast cancer cells. As the guanine nucleotide exchange factor of Rho GTPases, the r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Ming, Zhang, Di, Song, Bin, Zhao, Bin, Niu, Mengke, Wu, Yuze, Dai, Zhijun, Wu, Kongming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791744/ https://www.ncbi.nlm.nih.gov/pubmed/36572949 http://dx.doi.org/10.1186/s40164-022-00361-3

Ejemplares similares

Anti-TGF-β/PD-L1 bispecific antibody promotes T cell infiltration and exhibits enhanced antitumor activity in triple-negative breast cancer
por: Yi, Ming, et al.
Publicado: (2022)

Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
por: Wu, Yuze, et al.
Publicado: (2022)

TGF-β: A novel predictor and target for anti-PD-1/PD-L1 therapy
por: Yi, Ming, et al.
Publicado: (2022)

Recent advances in targeted strategies for triple-negative breast cancer
por: Zhu, Shuangli, et al.
Publicado: (2023)

Exploiting innate immunity for cancer immunotherapy
por: Yi, Ming, et al.
Publicado: (2023)

ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer
por: Daulat, Avais M., et al.
Publicado: (2019)

RDGN-based predictive model for the prognosis of breast cancer
por: Dong, Bing, et al.
Publicado: (2020)

Progression and prognostic value of ECT2 in non-small-cell lung cancer and its correlation with PCNA
por: Bai, Xianguang, et al.
Publicado: (2018)

Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
por: Niu, Mengke, et al.
Publicado: (2021)

Overexpression of ECT2 is a strong poor prognostic factor in ER(+) breast cancer
por: Xiu, Yingying, et al.
Publicado: (2019)

EYA2 Correlates With Clinico-Pathological Features of Breast Cancer, Promotes Tumor Proliferation, and Predicts Poor Survival
por: Xu, Hanxiao, et al.
Publicado: (2019)

ECT9 condensates with ECT1 and regulates plant immunity
por: Wang, Hui, et al.
Publicado: (2023)

Regulation of PD-L1 expression in the tumor microenvironment
por: Yi, Ming, et al.
Publicado: (2021)

Overexpression of FAM234B Predicts Poor Prognosis in Patients with Luminal Breast Cancer
por: Lyu, Lijuan, et al.
Publicado: (2020)

Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
por: Yi, Ming, et al.
Publicado: (2022)

Advances of Targeted Therapy for Hepatocellular Carcinoma
por: Niu, Mengke, et al.
Publicado: (2021)

Increased ATP2A1 Predicts Poor Prognosis in Patients With Colorectal Carcinoma
por: Zhang, Guoshun, et al.
Publicado: (2022)

Increased Expression of TAP Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer
por: Cheng, Yuanjun, et al.
Publicado: (2020)

Does ECT Work? the Impact of ECT on Depression
por: Collins, Dawn
Publicado: (2023)

Increased expression of miR-153 predicts poor prognosis for patients with prostate cancer
por: Bi, Cheng-wei, et al.
Publicado: (2019)

Upregulation of STAT1-CCL5 axis is a biomarker of colon cancer and promotes the proliferation of colon cancer cells
por: Niu, Mengke, et al.
Publicado: (2020)

Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer
por: Niu, Mengke, et al.
Publicado: (2022)

Cytoplasmic Pin1 expression is increased in human cutaneous melanoma and predicts poor prognosis
por: Chen, Xin, et al.
Publicado: (2018)

Increased expression of MMP9 is correlated with poor prognosis of nasopharyngeal carcinoma
por: Liu, Zhen, et al.
Publicado: (2010)

Role of Epithelial Cell Transforming Sequence 2 (ECT2) in Predicting Prognosis of Osteosarcoma
por: Chen, Zhiguo, et al.
Publicado: (2017)

VDAC1 Conversely Correlates with Cytc Expression and Predicts Poor Prognosis in Human Breast Cancer Patients
por: Chen, Fangfang, et al.
Publicado: (2021)

Correction to: Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies
por: Zhu, Shuangli, et al.
Publicado: (2022)

Recent advances and challenges of bispecific antibodies in solid tumors
por: Wu, Yuze, et al.
Publicado: (2021)

Roles of tumor-associated macrophages in tumor progression: implications on therapeutic strategies
por: Zhu, Shuangli, et al.
Publicado: (2021)

THE PRACTICE OF ECT IN INDIA: II. THE PRACTICAL ADMINISTRATION OF ECT
por: Andrade, Chittaranjan, et al.
Publicado: (1993)

Increased KIAA0101 gene expression associated with poor prognosis in breast cancer
por: Liu, Jiuyang, et al.
Publicado: (2021)

High expression of Linc00959 predicts poor prognosis in breast cancer
por: Chi, Weiru, et al.
Publicado: (2019)

CYC1 Predicts Poor Prognosis in Patients with Breast Cancer
por: Han, Yingyan, et al.
Publicado: (2016)

Increased expression of argininosuccinate synthetase protein predicts poor prognosis in human gastric cancer
por: SHAN, YAN-SHEN, et al.
Publicado: (2015)

The role of exosomes in liquid biopsy for cancer diagnosis and prognosis prediction
por: Li, Shiyu, et al.
Publicado: (2020)

REEVALUATION OF ECT
por: Abhyankar, Ravi
Publicado: (1985)

ECT Transport
por: Serge Pelletier, et al.
Publicado: (2007)

Effectiveness of Bifrontal ECT in Practice: A Comparison with Bitemporal ECT
por: Viswanath, Biju, et al.
Publicado: (2011)

THE PRACTICE OF ECT IN INDIA : ISSUES RELATING YO THE ADMINISTRATION OF ECT
por: Agarwal, A.K., et al.
Publicado: (1992)

SEIZURE DURATION OVER ECT SESSIONS: INFLUENCE OF SPACING ECTS
por: Janakiramaiah, N., et al.
Publicado: (1992)

Cannot write session to /tmp/vufind_sessions/sess_h3onso1pfrq5l17sei07g74rns